Models & Researchcancerdrug responsedrug blindbiomedical ml
Drug-blind monotherapy prediction shows intraclass limits
6.3
Monotherapy cancer drug-blind prediction is limited to intraclass generalization. The authors characterize the feature space of drug-blind prediction and show models generalize only within the same drug class when assessing efficacy of novel cancer drugs.
Key Points
- 1WHAT: Authors characterize the feature space of cancer drug-blind response prediction in detail.
- 2WHY: Predictive signals do not transfer across drug classes, constraining cross-class model performance.
- 3SO WHAT: Translational ML workflows must validate drug-blind models within drug classes for reliable use.
Scoring Rationale
This paper identifies a notable limitation in drug-response prediction models that matters to biomedical ML practitioners; it is an important but specialized finding rather than a broad field-changing result.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
